Health and Safety Code section 11351: Difference between revisions
No edit summary |
No edit summary |
||
Line 85: | Line 85: | ||
***Peyote | ***Peyote | ||
***Tetrahydrocannabinols | ***Tetrahydrocannabinols | ||
**Depressants | **Depressants | ||
**#Mecloqualone. | **#Mecloqualone. |
Revision as of 23:15, 14 April 2014
Health and Safety Code section 11351 prohibits the possession for sale of heroine, mescaline, peyote, THC, or a number of other specified substances. In addition to the list in 11350, it also prohibits possession for sale of certain depressants. It does not include cocaine base, but that is covered by HSC11351.5
Statute
Except as otherwise provided in this division, every person who possesses for sale or purchases for purposes of sale (1) any controlled substance specified in subdivision (b), (c), or (e) of Section 11054, specified in paragraph (14), (15), or (20) of subdivision (d) of Section 11054, or specified in subdivision (b) or (c) of Section 11055, or specified in subdivision (h) of Section 11056, or (2) any controlled substance classified in Schedule III, IV, or V which is a narcotic drug, shall be punished by imprisonment pursuant to subdivision (h) of Section 1170 of the Penal Code for two, three, or four years.
(Added by Stats.1972, c. 1407, p. 3012, § 3. Amended by Stats.1973, c. 1078, p. 2172, § 3, eff. Oct. 1, 1973; Stats.1975, c. 1087, p. 2648, § 2; Stats.1976, c. 1139, p. 5079, § 66, operative July 1, 1977; Stats.1983, c. 790, § 4; Stats.1984, c. 1635, § 51; Stats.1985, c. 1398, § 1.5; Stats.1987, c. 970, § 2; Stats.2000, c. 8 (S.B.550), § 4, eff. March 29, 2000; Stats.2011, c. 15 (A.B.109), § 152, eff. April 4, 2011, operative Oct. 1, 2011.)
Controlled substances covered in statute
- Schedule I
- Opiates
- Acetylmethadol
- Allylprodine
- Alphacetylmethadol (except levoalphacetylmethadol, also known as levo-alpha- acetylmethadol, levomethadyl acetate, or LAAM)
- Alphameprodine
- Alphamethadol
- Benzethidine
- Betacetylmethadol
- Betameprodine
- Betamethadol
- Betaprodine
- Clonitazene
- Dextromoramide
- Diampromide
- Diethylthiambutene
- Difenoxin
- Dimenoxadol
- Dimepheptanol
- Dimethylthiambutene
- Dioxaphetyl butyrate
- Dipipanone
- Ethylmethylthiambutene
- Etonitazene
- Etoxeridine
- Furethidine
- Hydroxypethidine
- Ketobemidone
- Levomoramide
- Levophenacylmorphan
- Morpheridine
- Noracymethadol
- Norlevorphanol
- Normethadone
- Norpipanone
- Phenadoxone
- Phenampromide
- Phenomorphan
- Phenoperidine
- Piritramide
- Proheptazine
- Properidine
- Propiram
- Racemoramide
- Tilidine
- Trimeperidine
- Acetylfentanyl (N-[1-phenethyl-4-piperidinyl] acetanilide)
- thiophene analog of acetylfentanyl (N-[1-[2-(2-thienyl)ethyl]-4-piperidinyl] acetanilide)
- 1-Methyl-4-Phenyl-4-Propionoxypiperidine (MPPP)
- 1-(2-Phenethyl)-4-Phenyl-4-Acetyloxypiperidine (PEPAP)
- Opium derivatives
- Acetorphine
- Acetyldihydrocodeine
- Benzylmorphine
- Codeine methylbromide
- Codeine-N-Oxide
- Cyprenorphine
- Desomorphine
- Dihydromorphine
- Drotebanol
- Etorphine (except hydrochloride salt)
- Heroin
- Hydromorphinol
- Methyldesorphine
- Methyldihydromorphine
- Morphine methylbromide
- Morphine methylsulfonate
- Morphine-N-Oxide
- Myrophine
- Nicocodeine
- Nicomorphine
- Normorphine
- Pholcodine
- Thebacon
- Hallucinogenic substances
- Mescaline
- Peyote
- Tetrahydrocannabinols
- Depressants
- Mecloqualone.
- Methaqualone.
- Gamma hydroxybutyric acid (also known by other names such as GHB; gamma hydroxy butyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate), including its immediate precursors, isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, including, but not limited to, gammabutyrolactone, for which an application has not been approved under Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355).
- Opiates
- Schedule II
- Opium
- Raw opium.
- Opium extracts.
- Opium fluid extracts.
- Powdered opium.
- Granulated opium.
- Tincture of opium.
- Codeine.
- Ethylmorphine.
- Hydrocodone.
- Hydromorphone.
- Metopon.
- Morphine.
- Oxycodone.
- Oxymorphone.
- Thebaine.
- Opium poppy and poppy straw.
- Coca leaves and any salt, compound, derivative, or preparation of coca leaves, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine.
- Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy).
- Cocaine, except as specified in Section 11054.
- Ecgonine, whether natural or synthetic, or any salt, isomer, derivative, or preparation thereof.
- Opiates. Unless specifically excepted or unless in another schedule, any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of those isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:
- Alfentanyl.
- Alphaprodine.
- Anileridine.
- Bezitramide.
- Bulk dextropropoxyphene (nondosage forms).
- Dihydrocodeine.
- Diphenoxylate.
- Fentanyl.
- Isomethadone.
- Levoalphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM. This substance is authorized for the treatment of narcotic addicts under federal law (see Part 291 (commencing with Section 291.501) and Part 1308 (commencing with Section 1308.01) of Title 21 of the Code of Federal Regulations).
- Levomethorphan.
- Levorphanol.
- Metazocine.
- Methadone.
- Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane.
- Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid.
- Pethidine (meperidine).
- Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.
- Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.
- Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid.
- Phenazocine.
- Piminodine.
- Racemethorphan.
- Racemorphan.
- Sufentanyl.
- Opium
- Schedule III
- Hallucinogenic substances
- dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the federal Food and Drug Administration.
- Narcotic drugs
- Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.
- Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
- Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.
- Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts. Additionally, oral liquid preparations of dihydrocodeinone containing the above specified amounts may not contain as its nonnarcotic ingredients two or more antihistamines in combination with each other.
- Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
- Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
- Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
- Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
- Hallucinogenic substances
- Schedule IV
- Narcotic drugs
- Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.
- Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane).
- Butorphanol.
- Narcotic drugs
- Schedule V
- Narcotic drugs
- Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.
- Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.
- Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.
- Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.
- Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.
- Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.
- Narcotic drugs